SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-042051
Filing Date
2024-04-01
Accepted
2024-04-01 18:58:00
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2410345-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2410345-1_3seq1.xml 3 1592
  Complete submission text file 0001104659-24-042051.txt   3291
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Hohneker John (Reporting) CIK: 0001695378 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 24811658